1376 - 1400 of 6403 Results
Title
Year
-
OPENTitle: A Neo-Substrate that Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1Journal Name: CellPublisher: Elsevier BVVol: 154Issue #: 4Start Page: 737End Page: 747Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.cell.2013.07.030Best OA location URL: https://escholarship.org/content/qt4qh7b302/qt4qh7b302.pdfCitation Count: 252
-
OPENTitle: Brain-restricted mTOR inhibition with binary pharmacologyJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 609Issue #: 7928Start Page: 822End Page: 828Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41586-022-05213-yBest OA location URL: https://escholarship.org/uc/item/30v9v9kdCitation Count: 60
-
OPENTitle: Use of Glycolysis‐Enhancing Drugs and Risk of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2210End Page: 2216Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.29184Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29184Citation Count: 23
-
OPENTitle: Caspase-1 causes truncation and aggregation of the Parkinson’s disease-associated protein α-synucleinJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 113Issue #: 34Start Page: 9587End Page: 9592Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1610099113Best OA location URL: https://www.pnas.org/content/pnas/113/34/9587.full.pdfCitation Count: 238
-
OPENTitle: Remote smartphone monitoring of Parkinson’s disease and individual response to therapyJournal Name: Nature BiotechnologyPublisher: Springer Science and Business Media LLCVol: 40Issue #: 4Start Page: 480End Page: 487Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41587-021-00974-9Best OA location URL: http://hdl.handle.net/2066/252104Citation Count: 117
-
OPENTitle: EndoMAP.v1 charts the structural landscape of human early endosome complexesJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 643Issue #: 8070Start Page: 252End Page: 261Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41586-025-09059-yBest OA location URL: https://www.nature.com/articles/s41586-025-09059-y.pdfCitation Count: 0
-
OPENTitle: Targeted micro-fiber arrays for measuring and manipulating localized multi-scale neural dynamics over large, deep brain volumes during behaviorJournal Name: NeuronPublisher: Elsevier BVVol: 112Issue #: 6Start Page: 909End Page: 923.e9Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neuron.2023.12.011Best OA location URL: https://escholarship.org/uc/item/9w19877gCitation Count: 14
-
OPENTitle: UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicalsJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 454Issue #: 7206Start Page: 846End Page: 851Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nature07181Best OA location URL: http://doi.org/10.1038/nature07181Citation Count: 685
-
OPENTitle: Dopamine neuron activity encodes the length of upcoming contralateral movement sequencesJournal Name: Current BiologyPublisher: Elsevier BVVol: 34Issue #: 5Start Page: 1034End Page: 1047.e4Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.cub.2024.01.067Best OA location URL: http://www.cell.com/article/S0960982224001040/pdfCitation Count: 6
-
OPENTitle: Accurate single-molecule spot detection for image-based spatial transcriptomics with weakly supervised deep learningJournal Name: Cell SystemsPublisher: Elsevier BVVol: 15Issue #: 5Start Page: 475End Page: 482.e6Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.cels.2024.04.006Best OA location URL: http://www.cell.com/article/S2405471224001212/pdfCitation Count: 9
-
OPENTitle: JNK2 and JNK3 combined are essential for apoptosis in dopamine neurons of the substantia nigra, but are not required for axon degenerationJournal Name: Journal of NeurochemistryPublisher: WileyVol: 107Issue #: 6Start Page: 1578End Page: 1588Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2008.05713.xBest OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1471-4159.2008.05713.x?download=trueCitation Count: 79
-
OPENTitle: Pitx3 is required for development of substantia nigra dopaminergic neuronsJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 100Issue #: 7Start Page: 4245End Page: 4250Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0230529100Best OA location URL: http://doi.org/10.1073/pnas.0230529100Citation Count: 382
-
OPENTitle: Regulation of Physiologic Actions of LRRK2: Focus on AutophagyJournal Name: Neurodegenerative DiseasesPublisher: S. Karger AGVol: 10Issue #: 1-4Start Page: 238End Page: 241Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1159/000332599Best OA location URL: https://www.karger.com/Article/Pdf/332599Citation Count: 39
-
OPENTitle: Triglycerides are an important fuel reserve for synapse function in the brainJournal Name: Nature MetabolismPublisher: Springer Science and Business Media LLCVol: 7Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s42255-025-01321-xBest OA location URL: https://www.nature.com/articles/s42255-025-01321-x.pdfCitation Count: 0
-
OPENTitle: The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasisJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 105Issue #: 1Start Page: 145End Page: 150Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.0710685105Best OA location URL: https://www.pnas.org/doi/pdf/10.1073/pnas.0710685105Citation Count: 512
-
OPENTitle: The unfolded protein response is activated in the olfactory system in Alzheimer’s diseaseJournal Name: Acta Neuropathologica CommunicationsPublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s40478-020-00986-7Best OA location URL: http://hdl.handle.net/2292/52610Citation Count: 37
-
OPENTitle: Pharmacological Characterization of Membrane-Expressed Human Trace Amine-Associated Receptor 1 (TAAR1) by a Bioluminescence Resonance Energy Transfer cAMP BiosensorJournal Name: Molecular PharmacologyPublisher: Elsevier BVVol: 74Issue #: 3Start Page: 585End Page: 594Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1124/mol.108.048884Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3766527Citation Count: 149
- BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein response2011OPENTitle: BAX inhibitor-1 regulates autophagy by controlling the IRE1α branch of the unfolded protein responseJournal Name: The EMBO JournalPublisher: Springer Science and Business Media LLCVol: 30Issue #: 21Start Page: 4465End Page: 4478Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/emboj.2011.318Best OA location URL: https://repositorio.uchile.cl/handle/2250/165394Citation Count: 112
- Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s disease2025OPENTitle: Haploinsufficiency of ITSN1 is associated with a substantial increased risk of Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 44Issue #: 3Start Page: 115355End Page: 115355Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2025.115355Best OA location URL: https://www.cell.com/action/showPdf?pii=S2211124725001263Citation Count: 2
-
OPENTitle: Open science takes on Parkinson’s diseaseJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.66546Best OA location URL: https://doi.org/10.7554/elife.66546Citation Count: 7
-
OPENTitle: Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tauJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 125Issue #: 2Start Page: 681End Page: 686Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1172/jci78421Best OA location URL: http://doi.org/10.1172/JCI78421Citation Count: 194
-
OPENTitle: Compounds from an unbiased chemical screen reverse both ER-to-Golgi trafficking defects and mitochondrial dysfunction in Parkinson’s disease modelsJournal Name: Disease Models & MechanismsPublisher: The Company of BiologistsVol: 3Issue #: 3-4Start Page: 194End Page: 208Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1242/dmm.004267Best OA location URL: http://doi.org/10.1242/dmm.004267Citation Count: 178
-
OPENTitle: A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 16Start Page: 1229End Page: 1236Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e3182516244Best OA location URL: https://n.neurology.org/content/neurology/78/16/1229.full.pdfCitation Count: 325
-
OPENTitle: Genetic variants and functional pathways associated with resilience to Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 143Issue #: 8Start Page: 2561End Page: 2575Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc, cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awaa209Best OA location URL: https://academic.oup.com/brain/article-pdf/143/8/2561/37356057/awaa209.pdfCitation Count: 126
-
OPENTitle: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2Journal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adt2050Best OA location URL: https://doi.org/10.1126/sciadv.adt2050Citation Count: 0